These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30797806)

  • 21. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and Characterization of Chitosan Nanoformulations for the Delivery of Antifungal Agents.
    Calvo NL; Sreekumar S; Svetaz LA; Lamas MC; Moerschbacher BM; Leonardi D
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
    Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
    Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amphotericin B-copper(II) complex as a potential agent with higher antifungal activity against Candida albicans.
    Chudzik B; Tracz IB; Czernel G; Fiołka MJ; Borsuk G; Gagoś M
    Eur J Pharm Sci; 2013 Aug; 49(5):850-7. PubMed ID: 23791641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of respirable nanomicelle carriers for delivery of amphotericin B by jet nebulization.
    Gilani K; Moazeni E; Ramezanli T; Amini M; Fazeli MR; Jamalifar H
    J Pharm Sci; 2011 Jan; 100(1):252-9. PubMed ID: 20602350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
    Alvarez C; Shin DH; Kwon GS
    Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation, Characterization, and Formulation Optimization of Ionic-Liquid-in-Water Nanoemulsions toward Systemic Delivery of Amphotericin B.
    Esson MM; Mecozzi S
    Mol Pharm; 2020 Jun; 17(6):2221-2226. PubMed ID: 32343901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
    Fu T; Yi J; Lv S; Zhang B
    J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and characterization of amphotericin B-polyethylenimine-dextran sulfate nanoparticles.
    Tiyaboonchai W; Woiszwillo J; Middaugh CR
    J Pharm Sci; 2001 Jul; 90(7):902-14. PubMed ID: 11458338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel performing PEG-cholane nanoformulation for Amphotericin B delivery.
    Luengo-Alonso C; Torrado JJ; Ballesteros MP; Malfanti A; Bersani S; Salmaso S; Caliceti P
    Int J Pharm; 2015 Nov; 495(1):41-51. PubMed ID: 26319629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations.
    Jansook P; Fülöp Z; Ritthidej GC
    Drug Dev Ind Pharm; 2019 Apr; 45(4):560-567. PubMed ID: 30632399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of polyion complex micelles for encapsulating and delivering amphotericin B.
    Wang CH; Wang WT; Hsiue GH
    Biomaterials; 2009 Jul; 30(19):3352-8. PubMed ID: 19299011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of amphotericin B from delivery systems and its action against fungal and mammalian cells.
    Legrand P; Chéron M; Leroy L; Bolard J
    J Drug Target; 1997; 4(5):311-9. PubMed ID: 9169988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B.
    Song Z; Wen Y; Deng P; Teng F; Zhou F; Xu H; Feng S; Zhu L; Feng R
    Carbohydr Polym; 2019 Feb; 205():571-580. PubMed ID: 30446143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.
    Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS
    Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro.
    Perez AP; Altube MJ; Schilrreff P; Apezteguia G; Celes FS; Zacchino S; de Oliveira CI; Romero EL; Morilla MJ
    Colloids Surf B Biointerfaces; 2016 Mar; 139():190-8. PubMed ID: 26709977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii.
    Batista-Duharte A; Lastre M; Romeu B; Portuondo DL; Téllez-Martínez D; Manente FA; Pérez O; Carlos IZ
    Int Immunopharmacol; 2016 Nov; 40():277-287. PubMed ID: 27639705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
    Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
    Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances of Sterculia gums uses in drug delivery systems.
    Silva JSFD; Oliveira ACJ; Soares MFR; Soares-Sobrinho JL
    Int J Biol Macromol; 2021 Dec; 193(Pt A):481-490. PubMed ID: 34710475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection.
    Yang Z; Chen M; Yang M; Chen J; Fang W; Xu P
    Int J Nanomedicine; 2014; 9():327-36. PubMed ID: 24421641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.